Table 3 Comparisons of demographic data and clinical features of surgical volume periods in liver transplantation patients
Demographic and clinical features | Annual surgical volumes < 30 (n = 74) | Annual surgical volumes ≥ 30 (n = 389) | p |
|---|---|---|---|
Mean ± SD (range) | Mean ± SD (range) | ||
Recipient age (years) | 51.88 ± 9.33 (11–70) | 54.37 ± 8.48 (18–73) | 0.023 |
Donor age (years) | 29.22 ± 8.13 (18.0–54.00) | 31.80 ± 9.34 (18.0–65.00) | 0.026 |
MELD score | 17.32 ± 8.95 (6.0–40.0) | 17.68 ± 9.43 (3.0–40.0) | 0.661 |
Total bilirubin (mg/dL) | 6.01 ± 9.10 (0.19–47.69) | 7.01 ± 9.72 (0.32–37.94) | 0.387 |
Creatinine (mg/dL) | 1.13 ± 0.81 (0.38–4.90) | 1.20 ± 0.99 (0.32–8.65) | 0.764 |
INR | 1.57 ± 0.71 (0.92–4.59) | 1.54 ± 0.62 (0.87–4.76) | 0.678 |
GRWR | 1.15 ± 0.31 (0.65–2.16) | 1.08 ± 0.30 (0.55–2.28) | 0.105 |
Blood loss (ml) | 6143.92 ± 5202.98 (200.0–23,000.0) | 3242.82 ± 3661.38 (200.0–40,000.0) | < 0.001 |
Operative time (min) | 474.51 ± 91.78 (290.00–730.00) | 398.26 ± 90.24 (215.00–885.00) | < 0.001 |
APACHE II score | 17.55 ± 7.00 (5.00–29.00) | 18.46 ± 7.24 (3.00–37.00) | 0.318 |
Intensive care unit (days) | 15.23 ± 10.03(4.0–58.00) | 9.63 ± 9.64 (1.00–114.00) | < 0.001 |
Length of stay (days) | 35.55 ± 17.38 (14.00–119.00) | 29.89 ± 17.38 (3.00–159.00) | 0.011 |
(%) | (%) | ||
|---|---|---|---|
Gender | 0.081 | ||
Male | 52 (70.3) | 309 (79.4) | |
Female | 22 (29.7) | 80 (20.6) | |
Pre-LT renal failure | 0.633 | ||
Yes | 3 (4.1) | 21 (5.4) | |
No | 71 (95.9) | 368 (94.6) | |
Pre-LT in intensive care unit | 0.237 | ||
Yes | 3 (4.1) | 31 (8.0) | |
No | 71 (95.9) | 358 (92.0) | |
ABO incompatible | < 0.001 | ||
Yes | 0 (0.0) | 54 (13.9) | |
No | 74 (100.0) | 335 (86.1) | |
Dialysis | 0.060 | ||
Yes | 13 (17.6) | 39 (10.0) | |
No | 61 (82.4) | 350 (90.0) | |
Re-operation | < 0.001 | ||
Yes | 29 (39.2) | 71 (18.3) | |
No | 45 (60.8) | 318 (81.7) | |
Biliary complication | 0.160 | ||
Yes | 12 (16.2) | 41 (10.5) | |
No | 62 (83.8) | 348 (89.5) | |
Hepatic artery complication | 0.849 | ||
Yes | 3 (4.1) | 14 (3.6) | |
No | 71 (95.9) | 375 (96.4) | |
Portal vein complication | 0.366 | ||
Yes | 0 (0.0) | 8(2.1) | |
No | 74 (100.0) | 381 (97.9) | |
Early allograft dysfunction | 0.376 | ||
Yes | 0 (0.0) | 10 (2.6) | |
No | 74 (100.0) | 379 (97.4) | |
Cardiovascular complication | 0.161 | ||
Yes | 3 (4.1) | 6 (1.5) | |
No | 71 (95.9) | 383 (98.5) | |
Cerebrovascular complication | 1.000 | ||
Yes | 1 (1.4) | 6 (1.5) | |
No | 73 (98.6) | 383 (98.5) | |
Pulmonary complication | 0.183 | ||
Yes | 12 (16.2) | 42 (10.8) | |
No | 62 (83.8) | 347 (89.2) | |
Hemorrhage | 0.099 | ||
Yes | 13 (17.6) | 42 (10.8) | |
No | 61 (82.4) | 347 (89.2) | |
Infection | 0.187 | ||
Yes | 28 (37.8) | 117 (30.1) | |
No | 46 (62.2) | 272 (69.9) | |
Hospital mortality | 0.030 | ||
Yes | 9 (12.2) | 21 (5.4) | |
No | 65 (87.8) | 368 (94.6) | |